KLRS – kalaris therapeutics, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

KLRS

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

4/16

05:12 am

klrs

Rating for KLRS

High Report

Rating for KLRS

Report

4/16

05:12 am

klrs

Rating for KLRS

High Report

Rating for KLRS

Report

4/16

05:03 am

klrs

Kalaris Therapeutics (KLRS) is now covered by Morgan Stanley. They set an "overweight" rating on the stock.

High Report

Kalaris Therapeutics (KLRS) is now covered by Morgan Stanley. They set an "overweight" rating on the stock.

Report

4/16

05:03 am

klrs

Kalaris Therapeutics (KLRS) is now covered by Morgan Stanley. They set an "overweight" rating on the stock.

High Report

Kalaris Therapeutics (KLRS) is now covered by Morgan Stanley. They set an "overweight" rating on the stock.

Report

4/16

04:54 am

klrs

Kalaris Therapeutics initiated with an Overweight at Morgan Stanley

High Report

Kalaris Therapeutics initiated with an Overweight at Morgan Stanley

Report

4/16

04:54 am

klrs

Kalaris Therapeutics initiated with an Overweight at Morgan Stanley

High Report

Kalaris Therapeutics initiated with an Overweight at Morgan Stanley

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.